Thu. Feb 2nd, 2023

ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based on peptide technology, opening opportunities for fruitful partnerships.

Hyderabad (Telangana) [India], April 29: ISSAR Pharmaceuticals, the Pioneer in Peptide Technology and peptide drug innovation, has decided to license out their peptide-based New Chemical Entities (NCEs), with pre-IND filing and US Patent. The potential collaboration would help ISSAR Pharmaceuticals in their goal to design and deliver novel peptide-based drugs for various unmet healthcare needs of the population and making them affordable and accessible for better health outcomes.

ISSAR Pharmaceuticals exclusively focuses on peptide technology-based research and development of New Chemical Entities (NCE) for various unmet medical needs to improve the quality of life. ISSAR uses Solid-phase peptide synthesis as the technology of choice and has the capability to synthesize custom peptides, API peptides, and cosmetic peptides at all scales within a short duration. With an emphasis on quality, safety, and innovation, ISSAR has demonstrated the ability to move products from conceptualisation to commercialisation of peptide molecules at all stages. ISSAR has several patents for potential life-changing peptide molecules lined up in their development pipeline targeting therapeutic areas such as oncology, dermatology, gastroenterology, and diseases of bones and joints.

We take pride in being India’s first-ever company to conduct phase-1 clinical trials and launch the first-ever indigenous peptide drug, Melgain in the market for the treatment of Vitiligo in 2004”, informs Mr. Ramakrishna Reddy Isanaka, the founder of ISSAR. ISSAR’s

FDA- compliant state-of-the-art manufacturing facility of 62000 sq. ft., is purely into peptide manufacturing technology, located in Genome Valley, Hyderabad, India. In addition to its experience in R&D, ISSAR is equipped with the most advanced and automatic technology with expertise in the synthesis and purification of peptides, producing the highest standards of purity of up to 99.5% by continued process optimization.

With over 25 years of experience and a prime focus in Research and Development, ISSAR’s dedicated team of experts is proud to have developed India’s first-ever peptide molecule, Melgain for the treatment of Vitiligo in 2004, which is now introduced as Novoskin® with improved properties and effectiveness. ISSAR’s commitment has also led to the development of their second New Chemical Entity called Xylentra, which is the first-ever peptide drug in the world for the treatment of burn wounds and microbial infections.

ISSAR developed molecules for prevalent conditions in the Western world such as Inflammatory Bowel Diseases (IBD), Psoriasis, and Sepsis. Recently, an NCE for the treatment of burn wounds (Xylentra) was licensed to Viatris, formerly known as Mylan Laboratories, the USA in 2020.

ISSAR Pharmaceuticals was founded by Mr. Ramakrishna Reddy Isanaka in 1995 with a vision to be a global leader in peptide drug discovery for improving patients’ quality of life. Before starting ISSAR Pharmaceutical, Mr.Isanaka was the promoter and director of Shantha Biotechnics in the 1980s, at a time when Biotechnology was new to India.

His efforts in research and development led to the advancement of ISSAR Pharma as the first-ever company in India to conduct Phase-I Clinical Trials in the year 1995. Today, he has over 25 years of experience in the development of NCEs with 2 successfully commercialized products, 7 plus patents to his credit, and over 6 commercially viable products under development.

https://issar.co.in/

By dsprime

48 thoughts on “ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs”
  1. Hello there! Do you know if they make any plugins to protect against hackers? I’m kinda paranoid about losing everything I’ve worked hard on. Any tips?

  2. Undeniably imagine that which you stated. Your favorite reason appeared to be at the internet the simplest factor to take into account of. I say to you, I certainly get annoyed at the same time as other folks consider worries that they plainly don’t recognise about. You controlled to hit the nail upon the highest and also outlined out the whole thing without having side-effects , folks could take a signal. Will probably be again to get more. Thanks

  3. hello there and thanks on your information – I’ve certainly picked up something new from right here. I did alternatively expertise several technical issues the use of this web site, as I skilled to reload the web site lots of times prior to I may get it to load correctly. I had been puzzling over if your hosting is OK? Now not that I am complaining, however slow loading circumstances occasions will very frequently affect your placement in google and can harm your high-quality rating if advertising and ***********|advertising|advertising|advertising and *********** with Adwords. Anyway I’m adding this RSS to my email and could glance out for much more of your respective fascinating content. Ensure that you replace this once more soon..

  4. I was wondering if you ever thought of changing the page layout of your website? Its very well written; I love what youve got to say. But maybe you could a little more in the way of content so people could connect with it better. Youve got an awful lot of text for only having 1 or 2 images. Maybe you could space it out better?

  5. I do love the manner in which you have framed this specific challenge and it does present us some fodder for consideration. On the other hand, because of what I have experienced, I really hope as the feedback pile on that individuals continue to be on issue and in no way start upon a soap box associated with some other news of the day. All the same, thank you for this outstanding piece and whilst I can not necessarily go along with this in totality, I respect the point of view.

  6. I’ve been exploring for a little bit for any high quality articles or blog posts on this kind of house . Exploring in Yahoo I finally stumbled upon this web site. Reading this info So i’m happy to exhibit that I’ve a very excellent uncanny feeling I came upon exactly what I needed. I most no doubt will make certain to do not overlook this web site and provides it a look regularly.

  7. 716079 809333The posh distributed could be described as distinctive; customers are actually yearning for bags is actually a Native aspirations. Which strange surroundings is built that is to market diversity furthermore importance with travel and leisure market trends. hotels unique offers 63396

  8. My spouse and i ended up being now satisfied that Ervin managed to finish up his basic research using the ideas he was given from your web page. It is now and again perplexing to just continually be releasing things which people today could have been selling. So we see we have got the blog owner to give thanks to for that. Those illustrations you’ve made, the easy web site menu, the friendships you will help instill – it’s got all awesome, and it’s making our son and our family know that that issue is amusing, which is incredibly fundamental. Thank you for all the pieces!

  9. Thank you for sharing excellent informations. Your website is very cool. I am impressed by the details that you?¦ve on this website. It reveals how nicely you understand this subject. Bookmarked this web page, will come back for extra articles. You, my friend, ROCK! I found simply the info I already searched all over the place and just could not come across. What a perfect website.

  10. 806356 936941Oh my goodness! a wonderful post dude. Thanks Nevertheless My business is experiencing concern with ur rss . Dont know why Not able to sign up for it. Possibly there is any person obtaining identical rss difficulty? Anyone who knows kindly respond. Thnkx 893689

  11. Hello! This is kind of off topic but I need some help from an established blog. Is it very hard to set up your own blog? I’m not very techincal but I can figure things out pretty fast. I’m thinking about creating my own but I’m not sure where to start. Do you have any ideas or suggestions? Thanks

  12. 181413 204724magnificent submit, really informative. I ponder why the opposite experts of this sector dont realize this. You need to proceed your writing. Im sure, youve a fantastic readers base already! 153163

  13. stavudine bactrim nedir niin kullanlr If you look at intra stock correlations, it would suggestthe market is becoming more fundamentally driven, SimonNicholas, senior fund manager at Brown Shipley, which managesassets worth around 4 billion pounds 6 cheapest priligy uk The economic evaluation will be conducted from the health services perspective

Leave a Reply

Your email address will not be published.